XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 68,012 $ 56,990
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for credit losses 8,522 3,553
Depreciation of premises and equipment 4,127 4,096
Net amortization of investment securities premiums and discounts 723 794
Amortization, fair market value adjustments and capitalization of servicing rights 404 3,290
Net gain on sales of investment securities 0 (18)
Net gain on mortgage banking activities (2,476) (3,945)
Bank owned life insurance income (4,879) (2,849)
Stock-based compensation 3,402 3,414
Intangible expenses 367 539
Other adjustments to reconcile net income to cash used in operating activities (2,528) (1,881)
Originations of loans held for sale (151,697) (235,166)
Proceeds from the sale of loans held for sale 164,291 234,788
Contributions to pension and other postretirement benefit plans (199) (187)
Increase in accrued interest receivable and other assets (7,260) (14,980)
Decrease in accrued interest payable and other liabilities (9,967) (1,376)
Net cash provided by operating activities 70,842 47,062
Cash flows from investing activities:    
Proceeds from sale of premises and equipment 427 2,450
Purchases of premises and equipment (3,915) (2,467)
Proceeds from maturities, calls and principal repayments of securities held-to-maturity 10,367 10,462
Proceeds from maturities, calls and principal repayments of securities available-for-sale 37,962 43,146
Proceeds from sales of securities available-for-sale 0 505
Purchases of investment securities held-to-maturity (2,546) (2,640)
Purchases of investment securities available-for-sale (34,849) (37,794)
Proceeds from sales of equity securities 5,430 3,437
Purchases of money market mutual funds (5,337) (2,482)
Net (increase) decrease in other investments (637) 264
Net decrease (increase) in loans and leases 28,499 (165,648)
Proceeds from sales of foreclosed / repossessed assets 275 68
Purchases of bank owned life insurance 0 (5,710)
Proceeds from bank owned life insurance 5,186 1,159
Net cash provided by (used in) investing activities 40,862 (155,250)
Cash flows from financing activities:    
Net increase in deposits 458,881 478,350
Net increase in short-term borrowings 770 1,950
Proceeds from issuance of long-term debt 50,000 0
Repayment of long-term debt (75,000) (85,000)
Early Repayment of Subordinated Debt (20,000) 0
Payment of contingent consideration on acquisitions (635) (635)
Payment for shares withheld to cover taxes on vesting of restricted stock units (1,596) (859)
Purchases of treasury stock (19,208) (14,706)
Stock issued under dividend reinvestment and employee stock purchase plans 1,732 1,855
Proceeds from exercise of stock options 323 877
Cash dividends paid (19,076) (18,743)
Net cash provided by financing activities 376,191 363,089
Net increase in cash and cash equivalents 487,895 254,901
Cash and cash equivalents at beginning of year 328,844 249,799
Cash and cash equivalents at end of period 816,739 504,700
Supplemental disclosures of cash flow information:    
Cash paid for interest 148,698 140,759
Cash paid for income taxes, net of refunds 14,479 15,740
Transfer of loans to other real estate owned 3,945 407
Transfer of leases to repossessed assets $ 78 $ 167